Austria vs Ghana: Treatment success rate for patients treated for MDR-TB
Austria
67.0%
in 2022
Ghana
67.0%
in 2022
Austria rank
106th
Ghana rank
106th
Treatment success rate for patients treated for MDR-TB over time
- Austria
- Ghana
How they compare
Austria currently reports 67.0% against 67.0% in Ghana, a difference of 0.0%.
The two have swapped places 7 times across 13 shared years of data; in 2010 it was Austria ahead.
Austria ranks 106th and Ghana ranks 106th of 163 countries.
Across the 2 decades both report, Austria averaged higher in 1 and Ghana in 1.
Head to head by decade
| Decade | Austria | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 71.8% | 62.3% | 9.5% | Austria |
| 2020s | 44.7% | 71.7% | 27.0% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Austria or Ghana?
- Austria, at 67.0% against 67.0% in Ghana as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Austria and Ghana?
- 0.0%, with Austria ahead.
- How many years of comparable data are there for Austria and Ghana?
- 13 years are reported by both, from 2010 to 2022.
- How do Austria and Ghana rank globally for treatment success rate for patients treated for mdr-tb?
- Austria ranks 106th and Ghana ranks 106th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.